News
Futures on Wall Street have begun trading from where they left off on Friday. The Dow futures are up 200 points, whereas the ...
It's a shot in the arm for Cambridge, Massachusetts-based Moderna as it faces an evolving regulatory environment for vaccines ...
Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved annual flu shot when tested in adults aged 50 years and older in a late-stage ...
mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI ... support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination vaccines." In a ...
Before the vaccines, such illnesses were the main reason why nearly one in five children in 1900 never made it to their fifth ...
As turmoil engulfed a federal vaccine advisory panel earlier this month, Massachusetts Department of Public Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results